CION Cancer Clinics
How liver metastases are monitored during treatment | CION Cancer Clinics
Liver metastases are mostly monitored by comparing scans, usually CT or MRI, taken before treatment and again after a few cycles. Liver blood tests, tumour markers and how you feel fill the gaps between scans. This page explains what is checked, how often, what the words on a follow-up report mean, and which symptoms should not wait for the next scheduled check. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
On this page
- How will the team know if treatment is working on the liver spots?
- What exactly gets checked between treatments?
- What does a typical round of monitoring look like?
- What do the words on a follow-up report mean?
- Is a scan that looks the same a bad sign?
- What this page cannot tell you
- Common questions about monitoring liver metastases
The short answer
How will the team know if treatment is working on the liver spots?
Mostly by comparing scans. A CT or MRI taken before treatment is put side by side with one taken a few cycles in, and the spots in the liver are measured on both. Blood tests and how you feel fill in the picture between scans.
This page is about secondary liver cancer: cancer that started somewhere else, such as the breast, lung, stomach or pancreas, and spread to the liver. If your cancer started in the liver itself, the follow-up plan is different and is explained on AFP after treatment. If the cancer started in the bowel, read the colon cancer page on bowel cancer spread to the liver.
Why monitoring matters so much here
Treatment for secondary liver cancer is usually given through the whole body, with chemotherapy, targeted therapy, hormone therapy or immunotherapy chosen for the original cancer. Monitoring answers one practical question each time: keep going, change the plan, or pause. It also spots the moment when a few liver spots shrink enough for surgery or ablation to come back on the table.
One scan is a snapshot. The decision usually rests on the trend across two or three.Four kinds of check
What exactly gets checked between treatments?
No single test tells the whole story. Your oncologist reads these four together.
Scans of the liver and body
Usually a contrast CT of the chest, abdomen and pelvis, sometimes an MRI of the liver, which shows small spots more clearly. A PET-CT is used for some cancers but not all. CION arranges these through accredited diagnostic partners.
Liver function tests
Bilirubin (the yellow pigment behind jaundice), albumin (a protein the liver makes) and liver enzymes. These show how well the liver is coping, not how big the spots are.
Tumour markers
Blood proteins some cancers release, such as CEA, CA 19-9, CA 15-3 or CA-125. They are useful only if they were raised at the start.
Read with care
- A single rise can be noise
- Some markers jump briefly when treatment starts working
- A normal marker does not rule out growth
How you are
Appetite, energy, pain under the right ribs, weight and any yellowing of the eyes. These count. A patient who feels better is often the first sign that treatment is helping.
Not sure whether this applies to you?
Ask an oncologistThe rhythm of follow-up
What does a typical round of monitoring look like?
A baseline scan before treatment
Everything later is compared with this one. If your first scan was done elsewhere, bring the actual images on a disc or link, not only the printed report.
Blood tests before each cycle
Blood counts and liver function are checked before every dose. A rising bilirubin can mean the dose needs adjusting or the plan needs a rethink.
A repeat scan after a few cycles
Typically every two to three months during active treatment, though your oncologist sets the timing to your cancer and your drugs. Using the same type of scan each time makes comparison fair.
Review at the tumour board
The radiologist's measurements, your blood results and how you are doing are discussed together, and the plan is confirmed or changed.
A clear conversation with you
You should leave knowing what the scan showed, what it means for treatment, and when the next check is due.
On your scan report
What do the words on a follow-up report mean?
- Target lesions
- The few spots the radiologist chooses to measure every time, so that the comparison stays consistent from scan to scan.
- Partial response
- The measured spots have shrunk clearly. This is a good result, even if they have not disappeared.
- Stable disease
- No meaningful growth and no meaningful shrinkage. On treatment for secondary cancer, stable is often a success, not a disappointment.
- Progressive disease
- The spots have grown beyond an agreed margin, or new spots have appeared. It usually means the current treatment should change.
- Complete response
- No visible cancer on the scan. It does not mean every cell is gone, so monitoring continues.
- RECIST
- The standard rulebook radiologists use to decide which of the labels above applies. You may see it named at the bottom of the report.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Is a scan that looks the same a bad sign?
Holding the cancer steady is one of the main aims of treatment for secondary liver cancer. Many people stay on the same plan for a long stretch with scans that read stable.
Scanning too often shows changes too small to measure reliably and adds radiation and cost. The interval is chosen so each scan can answer a real question.
Markers can rise for other reasons, including a temporary flare as treatment starts to work or a blocked bile duct. Doctors look at the trend and the scan before deciding.
Spots too small to see can still be there. This is why surgeons sometimes plan an operation before a spot disappears from view, and why follow-up continues after a good result.
Two radiologists reading the same scan can measure a liver spot slightly differently. Scans done at the same centre, on the same type of machine, with the earlier images available, make comparisons more reliable. Keep every disc.
Being straight with you
What this page cannot tell you
It cannot tell you how often your own scans should be done, which marker matters for your cancer, or what your latest report means. Those depend on where the cancer started, which treatment you are on and how your liver is coping. Your oncologist, with the radiologist and the tumour board, is the right person to read the trend.
Who this does not apply to
If your cancer began in the liver itself, monitoring leans heavily on AFP and on scans designed for liver tumours, and the decisions are different. If your doctor has said the liver is now struggling, read liver function when the liver is full of metastases, because the questions change.
When to call without waiting for the next scan
New yellowing of the eyes, a swelling tummy, new confusion or drowsiness, or vomiting blood should not wait for a scheduled check. Contact your treating team the same day, and go to hospital today if the person is confused, drowsy or bleeding.
If you are unsure what your last report said, bring it to your next appointment and ask for it in plain words.Questions we are asked
Common questions about monitoring liver metastases
How often will I need a scan during treatment?
Usually every two to three months while treatment is active, but this varies with the cancer and the drugs. Some treatments need an earlier check to confirm they are working. Your oncologist will tell you the plan and change it if your symptoms or blood tests suggest something has shifted.
Is CT or MRI better for watching liver spots?
MRI often shows small liver spots more clearly, while CT covers the chest, abdomen and pelvis in one go and is quicker. Many teams use CT routinely and add MRI when a liver question needs a sharper answer. Using the same scan type each time matters more than which one is chosen.
Do I need a PET-CT every time?
Usually not. PET-CT is helpful for some cancers and for particular questions, such as checking for spread outside the liver before surgery. For routine follow-up, CT or MRI is often enough. The page on PET-CT for liver metastases explains when it helps.
My tumour marker is rising but the scan looks stable. What now?
Your oncologist will usually look at the trend over more than one reading and may bring the next scan forward. A marker rise on its own is rarely enough to change treatment. Ask what level of change would make them act, so you know what to expect.
Can blood tests replace scans?
No. Blood tests show how the liver is coping and sometimes hint at what the cancer is doing, but they cannot show where the spots are or how big they have become. Scans and blood tests answer different questions and are read together.
What happens if the scan shows growth?
The team will usually discuss a change of treatment. There are often further options, depending on the original cancer, how fit you are and how well the liver is working. Sometimes a treatment aimed only at the liver is added. Growth is a reason to review the plan, not a reason to stop asking questions.
Should I get my scan done near home to save travel?
You can, but tell your team first. Scans done on different machines with different settings are harder to compare. If you do scan locally, ask for the images on a disc or link and bring the earlier scans too, so the radiologist can compare like with like.
Who can explain my follow-up report to me?
Your treating oncologist is the right person. If you are being treated elsewhere and want a second look, a CION oncologist can review your scans and reports with the tumour board. Call the helpline and someone will tell you what to bring.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Metastatic Cancer: When Cancer Spreads
- Cancer Research UK — Secondary liver cancer
- National Cancer Institute — Tumor Markers
- MedlinePlus — Liver Function Tests
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure what your last scan report means?
Send us your scans and reports, and a CION oncologist can go through them with you in plain words. One helpline serves every CION centre.